Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A LANDAU

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Gastroenterologie Clinique Et Biologique|June 8, 2001
[Suppurated hepatic metastasis revealing a colonic stromal tumor]S Ratel-Saby, P Ah-Hot, A Ratouis, et al.
Pest Management Science|November 21, 2023
First report of severe tolpyralate sensitivity in corn (Zea mays) discovers a novel genetic factor conferring crop response to a herbicideMartin M Williams, Nicholas E Hausman, Ana Saballos, et al.
Cell Systems|November 1, 2019
Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy OptimizationPatrick O Bolan, Asaf Zviran, Lisa Brenan, et al.
AIDS (London, England)|October 31, 2001
Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, C Piketty, et al.
STAR Protocols|March 21, 2024
GoT-Splice protocol for multi-omics profiling of gene expression, cell-surface proteins, mutational status, and RNA splicing in human cellsSaravanan Ganesan, Mariela Cortés-López, Ariel D Swett, et al.
Izvestiia Akademii Nauk. Seriia Biologicheskaia|July 1, 1997
[A computer study of the relationship between the value and type of their embryotoxicity and the structure of synthetic analogs of biogenic amines]I I Baskin, G A Buznikov, A S Kabankin, et al.
AIDS (London, England)|June 6, 2000
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, J P Duong Van Huyen, et al.
Scientific Reports|March 21, 2018
Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1Kirsten F Smit, Moritz Konkel, Raphaela Kerindongo, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
Nature Genetics|September 24, 2024
Defining heritability, plasticity, and transition dynamics of cellular phenotypes in somatic evolutionJoshua S Schiffman, Andrew R D'Avino, Tamara Prieto, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Gastroenterologie Clinique Et Biologique|June 8, 2001
[Suppurated hepatic metastasis revealing a colonic stromal tumor]S Ratel-Saby, P Ah-Hot, A Ratouis, et al.
Pest Management Science|November 21, 2023
First report of severe tolpyralate sensitivity in corn (Zea mays) discovers a novel genetic factor conferring crop response to a herbicideMartin M Williams, Nicholas E Hausman, Ana Saballos, et al.
Cell Systems|November 1, 2019
Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy OptimizationPatrick O Bolan, Asaf Zviran, Lisa Brenan, et al.
AIDS (London, England)|October 31, 2001
Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, C Piketty, et al.
STAR Protocols|March 21, 2024
GoT-Splice protocol for multi-omics profiling of gene expression, cell-surface proteins, mutational status, and RNA splicing in human cellsSaravanan Ganesan, Mariela Cortés-López, Ariel D Swett, et al.
Izvestiia Akademii Nauk. Seriia Biologicheskaia|July 1, 1997
[A computer study of the relationship between the value and type of their embryotoxicity and the structure of synthetic analogs of biogenic amines]I I Baskin, G A Buznikov, A S Kabankin, et al.
AIDS (London, England)|June 6, 2000
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, J P Duong Van Huyen, et al.
Scientific Reports|March 21, 2018
Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1Kirsten F Smit, Moritz Konkel, Raphaela Kerindongo, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
Nature Genetics|September 24, 2024
Defining heritability, plasticity, and transition dynamics of cellular phenotypes in somatic evolutionJoshua S Schiffman, Andrew R D'Avino, Tamara Prieto, et al.
Pageof 13